However, in our drug screen, the Akt-inhibitor Capivasertib did not induce apoptosis as effectively as TIC-10, potentially highlighting the importance of both Akt and ERK in venetoclax resistance in MCL. This evidence concerns the gene AKT1 and mantle cell lymphoma.